Northern Labrador tea, Rhododendron tomentosum ssp. subarcticum, is one of the most commonly used medicinal plants by Inuit and other First Nations peoples of Canada. The phenolic profile and seasonal variation of this commonly used medicinal plant remains largely unknown. To assess optimal harvesting time, R. tomentosum was collected in accordance with traditional knowledge practices bimonthly throughout the snow-free summer in Iqaluit, Nunavut. The antioxidant potency was measured in a DPPH radical scavenging assay, and the anti-inflammatory activity was determined with a TNF-α production assay. The seasonal variation of phenolic content was assessed with HPLC-DAD for fifteen of the most abundant phenolic compounds; (+)-catechin, chlorogenic acid, PARA-coumaric acid, quercetin 3-O-galactoside (hyperoside), quercetin 3-O-glucoside (isoquercitrin), quercetin 3-O-rhamnoside (quercitrin), quercetin pentoside, myricetin, quercetin, 3 procyanidins, and 3 caffeic acid derivatives. The most abundant constituent was (+)-catechin, which made up 19 % of the total weight of characterized phenolics. There was significant seasonal variation in the quantity of all fifteen constituents assessed, whereas there was no seasonal variation of their total sum. The antioxidant activity was positively correlated with phenolic content and negatively correlated with daylight hours. The anti-inflammatory activity was negatively correlated with caffeic acid derivative 1 and daylight hours. Together these results demonstrate that the timing of harvest of R. tomentosum impacts the plant's phenolic content and its antioxidant and anti-inflammatory activities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.